The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
onabotulinumtoxinA · BOTULINUM TOXIN TYPE A 100 [USP'U]/1 · Injection, Powder, Lyophilized, For Solution · Intradermal; Intramuscular · Sportpharm LLC
NDC 85766-0155-01 · 1 VIAL in 1 CARTON / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL · BLA · View full market →
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
There's no legal definition — it meets 3 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Allergan, Inc. | BOTULINUM TOXIN TYPE A 100 [USP'U]/1 | Jul 15, 2026 | Sep 3, 2026 |
| Allergan, Inc. | BOTULINUM TOXIN TYPE A 200 [USP'U]/1 | Jul 15, 2026 | Sep 2, 2026 |
| Allergan, Inc. | BOTULINUM TOXIN TYPE A 50 [USP'U]/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sportpharm LLC | BOTULINUM TOXIN TYPE A 100 [USP'U]/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Botox — NDC 85766-0155-01," retrieved September 3, 2026, https://drugdashboards.com/drug/85766015501.
Free to cite with attribution — see how the data is put together.